Peptic ulcer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 15: Line 15:
*The prevalence of peptic ulcer disease is approximately 23.1 per 100,000 individuals but higher in men 29.4 per 100,000  than women 14.9 per 100,000
*The prevalence of peptic ulcer disease is approximately 23.1 per 100,000 individuals but higher in men 29.4 per 100,000  than women 14.9 per 100,000
*The prevalence of peptic ulcer disease  is estimated to be 4.5 million cases annually.
*The prevalence of peptic ulcer disease  is estimated to be 4.5 million cases annually.
*Lifetime prevalence is  11-14% in men and 8-11% in women<ref name="pmid16165708">{{cite journal |vauthors=Ohmann C, Imhof M, Ruppert C, Janzik U, Vogt C, Frieling T, Becker K, Neumann F, Faust S, Heiler K, Haas K, Jurisch R, Wenzel EG, Normann S, Bachmann O, Delgadillo J, Seidel F, Franke C, Lüthen R, Yang Q, Reinhold C |title=Time-trends in the epidemiology of peptic ulcer bleeding |journal=Scand. J. Gastroenterol. |volume=40 |issue=8 |pages=914–20 |year=2005 |pmid=16165708 |doi=10.1080/00365520510015809 |url=}}</ref>
*Lifetime prevalence is  11-14% in men and 8-11% in women<ref name="pmid16165708">{{cite journal |vauthors=Ohmann C, Imhof M, Ruppert C, Janzik U, Vogt C, Frieling T, Becker K, Neumann F, Faust S, Heiler K, Haas K, Jurisch R, Wenzel EG, Normann S, Bachmann O, Delgadillo J, Seidel F, Franke C, Lüthen R, Yang Q, Reinhold C |title=Time-trends in the epidemiology of peptic ulcer bleeding |journal=Scand. J. Gastroenterol. |volume=40 |issue=8 |pages=914–20 |year=2005 |pmid=16165708 |doi=10.1080/00365520510015809 |url=}}</ref><ref name="pmid17703249">{{cite journal |vauthors=Naja F, Kreiger N, Sullivan T |title=Helicobacter pylori infection in Ontario: prevalence and risk factors |journal=Can. J. Gastroenterol. |volume=21 |issue=8 |pages=501–6 |year=2007 |pmid=17703249 |pmc=2657974 |doi= |url=}}</ref><ref name="pmid19220208">{{cite journal |vauthors=Sung JJ, Kuipers EJ, El-Serag HB |title=Systematic review: the global incidence and prevalence of peptic ulcer disease |journal=Aliment. Pharmacol. Ther. |volume=29 |issue=9 |pages=938–46 |year=2009 |pmid=19220208 |doi=10.1111/j.1365-2036.2009.03960.x |url=}}</ref><ref name="pmid8547530">{{cite journal |vauthors=Kuipers EJ, Thijs JC, Festen HP |title=The prevalence of Helicobacter pylori in peptic ulcer disease |journal=Aliment. Pharmacol. Ther. |volume=9 Suppl 2 |issue= |pages=59–69 |year=1995 |pmid=8547530 |doi= |url=}}</ref><ref name="pmid8547526">{{cite journal |vauthors=Pounder RE, Ng D |title=The prevalence of Helicobacter pylori infection in different countries |journal=Aliment. Pharmacol. Ther. |volume=9 Suppl 2 |issue= |pages=33–9 |year=1995 |pmid=8547526 |doi= |url=}}</ref>
<ref name="pmid17703249">{{cite journal |vauthors=Naja F, Kreiger N, Sullivan T |title=Helicobacter pylori infection in Ontario: prevalence and risk factors |journal=Can. J. Gastroenterol. |volume=21 |issue=8 |pages=501–6 |year=2007 |pmid=17703249 |pmc=2657974 |doi= |url=}}</ref><ref name="pmid19220208">{{cite journal |vauthors=Sung JJ, Kuipers EJ, El-Serag HB |title=Systematic review: the global incidence and prevalence of peptic ulcer disease |journal=Aliment. Pharmacol. Ther. |volume=29 |issue=9 |pages=938–46 |year=2009 |pmid=19220208 |doi=10.1111/j.1365-2036.2009.03960.x |url=}}</ref><ref name="pmid8547530">{{cite journal |vauthors=Kuipers EJ, Thijs JC, Festen HP |title=The prevalence of Helicobacter pylori in peptic ulcer disease |journal=Aliment. Pharmacol. Ther. |volume=9 Suppl 2 |issue= |pages=59–69 |year=1995 |pmid=8547530 |doi= |url=}}</ref><ref name="pmid8547526">{{cite journal |vauthors=Pounder RE, Ng D |title=The prevalence of Helicobacter pylori infection in different countries |journal=Aliment. Pharmacol. Ther. |volume=9 Suppl 2 |issue= |pages=33–9 |year=1995 |pmid=8547526 |doi= |url=}}</ref>
 
===Age===
===Age===
*Peptic ulcer disease is acquired during childhood.
*Peptic ulcer disease is acquired during childhood.

Revision as of 17:25, 16 November 2017

Peptic ulcer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peptic Ulcer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Endoscopic management
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

2017 ACG Guidelines for Peptic Ulcer Disease

Guidelines for the Indications to Test for, and to Treat, H. pylori Infection

Guidelines for First line Treatment Strategies of Peptic Ulcer Disease for Providers in North America

Guidlines for factors that predict the successful eradication when treating H. pylori infection

Guidelines to document H. pylori antimicrobial resistance in the North America

Guidelines for evaluation and testing of H. pylori antibiotic resistance

Guidelines for when to test for treatment success after H. pylori eradication therapy

Guidelines for penicillin allergy in patients with H. pylori infection

Guidelines for the salvage therapy

Peptic ulcer epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peptic ulcer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peptic ulcer epidemiology and demographics

CDC on Peptic ulcer epidemiology and demographics

Peptic ulcer epidemiology and demographics in the news

Blogs on Peptic ulcer epidemiology and demographics

to Hospitals Treating Peptic ulcer

Risk calculators and risk factors for Peptic ulcer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence of peptic ulcer disease is approximately 10-19 per 100,000 individuals worldwide.[1]
  • In 2011, the incidence rate of peptic ulcer disease was estimated to be one case per 1000 individuals and peptic ulcer complications is 0.7 per 1000 individuals.[2]
  • The incidence and prevalence of H. pylori infection are generally higher among people born outside North America. Within North America, the prevalence of the infection is higher in certain racial and ethnic groups, and people who have immigrated to North America

Prevalence

  • The prevalence of peptic ulcer disease is approximately 23.1 per 100,000 individuals but higher in men 29.4 per 100,000 than women 14.9 per 100,000
  • The prevalence of peptic ulcer disease is estimated to be 4.5 million cases annually.
  • Lifetime prevalence is 11-14% in men and 8-11% in women[3][4][1][5][6]

Age

  • Peptic ulcer disease is acquired during childhood.
  • The incidence of Peptic ulcer disease increases with age; the median age at diagnosis is years.

.

Race

  • Peptic ulcer disease usually affects individuals of the African Americans with a higher proportion of African ancestry race and Mexican Americans[7][8].Non-Hispanic whites individuals are less likely to develop the peptic ulcer disease.


Gender

  • Peptic ulcer disease for male and female are similar in childhood[9].
  • Men are more commonly affected by peptic ulcer disease than women in adulhood[4].

References

  1. 1.0 1.1 Sung JJ, Kuipers EJ, El-Serag HB (2009). "Systematic review: the global incidence and prevalence of peptic ulcer disease". Aliment. Pharmacol. Ther. 29 (9): 938–46. doi:10.1111/j.1365-2036.2009.03960.x. PMID 19220208.
  2. Lin KJ, García Rodríguez LA, Hernández-Díaz S (2011). "Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?". Pharmacoepidemiol Drug Saf. 20 (7): 718–28. doi:10.1002/pds.2153. PMID 21626606.
  3. Ohmann C, Imhof M, Ruppert C, Janzik U, Vogt C, Frieling T, Becker K, Neumann F, Faust S, Heiler K, Haas K, Jurisch R, Wenzel EG, Normann S, Bachmann O, Delgadillo J, Seidel F, Franke C, Lüthen R, Yang Q, Reinhold C (2005). "Time-trends in the epidemiology of peptic ulcer bleeding". Scand. J. Gastroenterol. 40 (8): 914–20. doi:10.1080/00365520510015809. PMID 16165708.
  4. 4.0 4.1 Naja F, Kreiger N, Sullivan T (2007). "Helicobacter pylori infection in Ontario: prevalence and risk factors". Can. J. Gastroenterol. 21 (8): 501–6. PMC 2657974. PMID 17703249.
  5. Kuipers EJ, Thijs JC, Festen HP (1995). "The prevalence of Helicobacter pylori in peptic ulcer disease". Aliment. Pharmacol. Ther. 9 Suppl 2: 59–69. PMID 8547530.
  6. Pounder RE, Ng D (1995). "The prevalence of Helicobacter pylori infection in different countries". Aliment. Pharmacol. Ther. 9 Suppl 2: 33–9. PMID 8547526.
  7. Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M, Cole R, Anand B, Vela M, El-Serag HB (2015). "The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans". Helicobacter. 20 (4): 305–15. doi:10.1111/hel.12199. PMID 25689684.
  8. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G (2000). "Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States". J. Infect. Dis. 181 (4): 1359–63. doi:10.1086/315384. PMID 10762567.
  9. de Martel C, Parsonnet J (2006). "Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys". Dig. Dis. Sci. 51 (12): 2292–301. doi:10.1007/s10620-006-9210-5. PMID 17089189.

Template:WH Template:WS